Revisión sobre prevención y tratamiento de la mucositis oral en cáncer de cabeza y cuello

  1. Alba BARTOLOMÉ-ALONSO
  2. José Luis PARDAL-REFOYO
Revue:
Revista ORL

ISSN: 2444-7986,  2444-7986

Année de publication: 2019

Volumen: 10

Volumen: 4

Pages: 269-277

Type: Article

DOI: 10.14201/ORL.20688 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

D'autres publications dans: Revista ORL

Résumé

Introduction: One of the most serious side effects of radiotherapy and chemotherapy in head and neck cancer is oral mucositis or inflammation of the mucosa of the gastrointestinal tract, causing pain and impossibility of a correct intake. Objective: To investigate the interventions that can be developed by the nursing professional to prevent and treat oral mucositis in patients treated for head and neck cancer. Method: A literature search was carried out in PubMed, CUIDEN, CINAHL, Trip, Cochrane, Medes and Epistemonikos databases. Finally, eight articles were selected in which their qualitative analysis was carried out. Results: The most relevant interventions are good oral hygiene and care, saline rinses, sodium bicarbonate, thyme honey and morphine or doxepin solutions, as well as cryotherapy, phototherapy, gabapentin as an adjuvant and Episil® rinse . The use of chlorhexidine is discouraged. Conclusions: Hygiene and oral care are important for the prevention and treatment of mucositis, helping to carry out radiotherapy or chemotherapy without interruptions. The use of mouthwashes, gabapentin, phototherapy and cryotherapy reduce pain and reduce the severity of mucositis.

Références bibliographiques

  • 1. Cárcamo M. Epidemiología y generalidades del tumor de cabeza y cuello. Rev Médica Clínica Las Condes [Internet]. julio de 2018 [consultado 21 feb 2019];29(4):388-96. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/ S0716864018300920.
  • 2. Silvestre-Donat FJ, Puente Sandoval A. Efectos adversos del tratamiento del cáncer oral. Av Odontoestomatol [Internet]. 2008 [consultado 23 feb 2019];24(1):111-21. Disponible en: http://scielo. isciii.es/pdf/odonto/v24n1/original11.pdf.
  • 3. Alonso Castell P, Basté Dencás MA, Creus Viles M, Del Pino Gaya B, Gómez Blasco C, Goméz Gener A, et al. Prevención y tratamiento de la mucositis en el paciente onco-hematológico. Farm Hosp [Internet]. 2001 [consultado 19 feb 2019];25(3):139-49. Disponible en: https://gruposdetrabajo.sefh.es/gedefo/images/stories/documentos/Web_FH_01_25_139.pdf.
  • 4. Gallego C. La mucositis, un efecto del tratamiento quimioterapéutico: fisiopatología y manejo. Rev Fac Odontol Univ Antioq. 2007;18(2):84-92.
  • 5. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;6(7):e1000100.
  • 6. Aapro M, Abadi S, Abbott CA, Abernethy A, Abernethy AP, Abimosleh SM, et al. MASCC 2012 Abstracts. Support Care Cancer. 2012;20(S1):1-283.
  • 7. Gouveia E, Roldão M, Martins L, Ferreira M, Esteves S, Netto E, et al. PO-127: Prevention and treatment of oral mucositis in patients treated with chemoradiotherapy with head and neck cancer. Radiother Oncol [Internet]. 2015 [consultado 6 mar 2019];114:61-2. Disponible en: http://dx.doi. org/10.1016/S0167-8140(15)34887-8.
  • 8. Cheng K, Lee J, Leung SF, Liang R, Tai J, Yeung R, et al. Use of Rasch analysis in the evaluation of the oropharyngeal mucositis quality of life scale. Nurs Res. 2011;60(4):256-63.
  • 9. Riley P, Glenny AM, Worthington HV, Littlewood A, Fernandez Mauleffinch LM, Clarkson JE, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: Cytokines and growth factors. Cochrane Database Syst Rev. 2017;(11):1-35.
  • 10. Mesquita Araújo SN, Barros Araújo Luz MH, Freitas da Silva GR, Leite Rangel Andrate EM, Cunha Nunes LC, Olivera Moura R. El paciente oncológico con mucositis oral: desafíos para el cuidado de enfermería. Rev Lat Am Enfermagem. 2015;23(2):267-74.
  • 11. Charalambous M, Raftopoulos V, Lambrinou E, Charalambous A. The effectiveness of honey for the management of radiotherapy-induced oral mucositis in head and neck cancer patients: A systematic review of clinical trials. Eur J Integr Med [Internet]. 2013[consultado 6 mar 2019];5(3):217-25. Disponible en: http://dx.doi. org/10.1016/j.eujim.2013.01.003.
  • 12. Costa Normado A, Lopes Rocha C, Porto de Toledo I, Tadeu de Souza Figueiredo P, Diniz dos Reis P, De Luca Canto G, et al. Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and metaanalysis. Support Care Cancer. 2017;25(9):296988.
  • 13. Xiu-E L, Wei-Qing Ch, Li-Juan Y, Xu T, Ting S, Hui Ch, et al. Prophylaxis with oral zinc sulfate against radiation-induced oropharyngeal mucositis in patients with head and neck cancer. Medicine (Baltimore). 2018;97(48):e13310.
  • 14. Stenstrom Ling I, Larsson B. Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy. Support Care Cancer 2011;19:134350.
  • 15. Demir Dogan M, Can G MR. Effectiveness of Black Mulberry Molasses in Prevention of Radiotherapy-Induced Oral Mucositis: A Randomized Controlled Study in Head and Neck Cancer Patients. J Altern Complement Med. 2017;23(12):971-9.
  • 16. Chen S, Lai Y, Huang B, Lin Ch, Fan K, TungChien Chang J. Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment. Eur J Oncol Nurs [Internet]. 2014 [consultado 6 mar 2019];19(3):214-9. Disponible en: http://dx.doi. org/10.1016/j.ejon.2014.12.001.
  • 17. Muñoz-Corcuera M, González-Nieto A, LópezPintor Muñoz R. Utilización del láser para la prevención y el tratamiento de la mucositis oral inducida por quimioterapia y radioterapia de cabeza y cuello. Med Clin (Barc). 2013;143(4):170-5.
  • 18. B McGuire D, S Fulton J, Park J, G.Brown C, P Correa ME, Eilers J, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3165-77.
  • 19. Delgado Riffo C, Orellana-Yáñez A. Cuidados de enfermería en prevención de mucositis oral secundaria al tratamiento oncológico : una revisión integrativa. ENE enf 2019;16:1-6.
  • 20. Hadjieva T, Cavallin-Stahl E, Linden M, Tiberg F. Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution. Support Care Cancer 2014;22:1557-62.
  • 21. Milazzo-Kiedaisch C, Itano J, Dutta P. Role of gabapentin in managing mucositis pain in patients undergoing radiation therapy to the head and neck. Clin J Oncol Nurs. 2016;20(6):623-8.
  • 22. Charalambous M, Raftopoulos V, Paikousis L, Katodritis N, Lambrinou E, Vomvas D, et al. The effect of the use of thyme honey in minimizing radiation induced oral mucositis in head and neck cancer patients: A randomized controlled trial. Eur J Oncol Nurs [Internet]. 2018 [consultado 7 mar 2019];34:89-97. Disponible en: https:// doi.org/10.1016/j.ejon.2018.04.003.
  • 23. Peña Molinero C, Manso Melgosa A, González Casado R, Santillán García A, Febrero Ortiz de Quintana A, Ortega Barriuso R. Cuidados de enfermería en la mucositis del paciente oncológico: revisión de evidencias. Ene [Internet]. 2007[consultado 7 mar 2019];11(2):1-6. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_ abstract&pid=S1988-348X2017000200007.
  • 24. Tachibana H, Kubo T, Kubota K, Yokota T, Sakai K, Sato M, et al. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy. Support Care Cancer. 2016; 24(7):3029-36.
La source de données: Dialnet